Patents by Inventor Jamie Wong

Jamie Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160200815
    Abstract: Provided herein are embodiments relating to therapeutic applications of antibodies that modulate; e.g., inhibit the interaction of TIM-3 and LILRB2 antibodies. In some embodiments, the antibodies bind TIM-3. In some embodiments the antibodies bind LILRB2. Modulation of the interaction of TIM-3 and LILRB2 stimulates the release of pro-inflammatory cytokines; e.g., myeloid-associated pro-inflammatory cytokines.
    Type: Application
    Filed: January 4, 2016
    Publication date: July 14, 2016
    Inventors: Igor FELDMAN, Tatiana NOVOBRANTSEVA, Jamie WONG, Ryan PHENNICIE, Stephen Sazinsky, Sriram Sathyanarayanan
  • Publication number: 20140328811
    Abstract: The technology described herein relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the genes encoding negative regulators of MHC expansion (e.g. AhR, Itch, Prox1 and/or SH2B3), and methods of using such dsRNA compositions to inhibit expression of negative regulators of MHC expansion. The use of such compositions to provide, for example, enhanced quantitites and/or qualities of MHCs and/or hematopoietic progenitor cells for transplantation and/or to enhance engraftment of transplanted MHCs hematopoietic progenitor cells is described.
    Type: Application
    Filed: August 1, 2012
    Publication date: November 6, 2014
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Jamie Wong, Brian Bettencourt